GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Equity-to-Asset

International Biotechnology Trust (LSE:IBT) Equity-to-Asset : 0.89 (As of Feb. 2024)


View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. International Biotechnology Trust's Total Stockholders Equity for the quarter that ended in Feb. 2024 was £286.51 Mil. International Biotechnology Trust's Total Assets for the quarter that ended in Feb. 2024 was £320.77 Mil. Therefore, International Biotechnology Trust's Equity to Asset Ratio for the quarter that ended in Feb. 2024 was 0.89.

The historical rank and industry rank for International Biotechnology Trust's Equity-to-Asset or its related term are showing as below:

LSE:IBT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.85   Med: 0.94   Max: 1
Current: 0.89

During the past 13 years, the highest Equity to Asset Ratio of International Biotechnology Trust was 1.00. The lowest was 0.85. And the median was 0.94.

LSE:IBT's Equity-to-Asset is ranked better than
59.64% of 1727 companies
in the Asset Management industry
Industry Median: 0.82 vs LSE:IBT: 0.89

International Biotechnology Trust Equity-to-Asset Historical Data

The historical data trend for International Biotechnology Trust's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Equity-to-Asset Chart

International Biotechnology Trust Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.94 0.93 0.87 0.89

International Biotechnology Trust Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.85 0.87 0.89 0.89 0.89

Competitive Comparison of International Biotechnology Trust's Equity-to-Asset

For the Asset Management subindustry, International Biotechnology Trust's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


International Biotechnology Trust's Equity-to-Asset Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, International Biotechnology Trust's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where International Biotechnology Trust's Equity-to-Asset falls into.



International Biotechnology Trust Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

International Biotechnology Trust's Equity to Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Equity to Asset (A: Aug. 2023 )=Total Stockholders Equity/Total Assets
=270.317/304.871
=0.89

International Biotechnology Trust's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=286.509/320.769
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


International Biotechnology Trust  (LSE:IBT) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


International Biotechnology Trust Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


International Biotechnology Trust (LSE:IBT) Business Description

Traded in Other Exchanges
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines